Nature of Disclosure: Regulatory filing pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, intimating about an upcoming board meeting.
Board Meeting Details: A meeting of the Board of Directors is scheduled to be held on Friday, November 6, 2026, to transact the following business:
- Consider and approve the Standalone and Consolidated unaudited financial results for the quarter and half year ended September 30, 2026, along with the Limited Review Report
- Consider and reconstitute the Committees of the Company
- Any other matter with the permission of the Chairman
Trading Window Closure: As previously intimated to the exchange via letter dated September 29, 2026, the trading window for dealing in the company's securities remains closed for all designated persons and their immediate relatives. The closure period began on October 1, 2026, and will continue until 48 hours after the announcement of the unaudited financial results for the quarter and half year ended September 30, 2026. This is in compliance with the Company's Code of Conduct for prevention of Insider Trading and SEBI (Prohibition of Insider Trading) Regulations, 2015.